450 related articles for article (PubMed ID: 16048985)
1. In vivo transfer of plasmid-encoded ACC-1 AmpC from Klebsiella pneumoniae to Escherichia coli in an infant and selection of impermeability to imipenem in K. pneumoniae.
Bidet P; Burghoffer B; Gautier V; Brahimi N; Mariani-Kurkdjian P; El-Ghoneimi A; Bingen E; Arlet G
Antimicrob Agents Chemother; 2005 Aug; 49(8):3562-5. PubMed ID: 16048985
[TBL] [Abstract][Full Text] [Related]
2. Association of QnrB determinants and production of extended-spectrum beta-lactamases or plasmid-mediated AmpC beta-lactamases in clinical isolates of Klebsiella pneumoniae.
Pai H; Seo MR; Choi TY
Antimicrob Agents Chemother; 2007 Jan; 51(1):366-8. PubMed ID: 17074790
[TBL] [Abstract][Full Text] [Related]
3. ACT-3, a novel plasmid-encoded class C beta-lactamase in a Klebsiella pneumoniae isolate from China.
Chen Y; Cheng J; Wang Q; Ye Y; Li JB; Zhang XJ
Int J Antimicrob Agents; 2009 Jan; 33(1):95-6. PubMed ID: 18789849
[No Abstract] [Full Text] [Related]
4. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.
Bradford PA; Urban C; Mariano N; Projan SJ; Rahal JJ; Bush K
Antimicrob Agents Chemother; 1997 Mar; 41(3):563-9. PubMed ID: 9055993
[TBL] [Abstract][Full Text] [Related]
5. Carbapenem-resistant Escherichia coli and Klebsiella pneumoniae isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss.
Gülmez D; Woodford N; Palepou MF; Mushtaq S; Metan G; Yakupogullari Y; Kocagoz S; Uzun O; Hascelik G; Livermore DM
Int J Antimicrob Agents; 2008 Jun; 31(6):523-6. PubMed ID: 18339523
[TBL] [Abstract][Full Text] [Related]
6. Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein.
Dahmen S; Mansour W; Charfi K; Boujaafar N; Arlet G; Bouallègue O
Microb Drug Resist; 2012 Oct; 18(5):479-83. PubMed ID: 22690752
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Park YJ; Yu JK; Park KG; Park YG; Lee S; Kim SY; Jeong SH
Diagn Microbiol Infect Dis; 2011 Sep; 71(1):87-9. PubMed ID: 21397426
[TBL] [Abstract][Full Text] [Related]
8. Transconjugation and genotyping of the plasmid-mediated AmpC beta-lactamase and extended-spectrum beta-lactamase genes in Klebsiella pneumoniae.
Shi WF; Zhou J; Qin JP
Chin Med J (Engl); 2009 May; 122(9):1092-6. PubMed ID: 19493446
[TBL] [Abstract][Full Text] [Related]
9. [Identification of a plasmid-mediated AmpC beta-lactamase from clinical isolates of Escherichia coli and Klebsiella pneumoniae].
Wang Y; Li ZH
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Oct; 28(10):685-8. PubMed ID: 16255953
[TBL] [Abstract][Full Text] [Related]
10. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
11. In vivo selection of imipenem-resistant Klebsiella pneumoniae producing extended-spectrum beta-lactamase CTX-M-15 and plasmid-encoded DHA-1 cephalosporinase.
Cuzon G; Naas T; Guibert M; Nordmann P
Int J Antimicrob Agents; 2010 Mar; 35(3):265-8. PubMed ID: 20034767
[TBL] [Abstract][Full Text] [Related]
12. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae and Escherichia coli isolates possessing blaVIM-1 in Greece.
Galani I; Souli M; Mitchell N; Chryssouli Z; Giamarellou H
Int J Antimicrob Agents; 2010 Sep; 36(3):252-4. PubMed ID: 20580536
[TBL] [Abstract][Full Text] [Related]
13. Sources of diversity of carbapenem resistance levels in Klebsiella pneumoniae carrying blaVIM-1.
Loli A; Tzouvelekis LS; Tzelepi E; Carattoli A; Vatopoulos AC; Tassios PT; Miriagou V
J Antimicrob Chemother; 2006 Sep; 58(3):669-72. PubMed ID: 16870645
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae.
Lee K; Hong SG; Park YJ; Lee HS; Song W; Jeong J; Yong D; Chong Y
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222
[TBL] [Abstract][Full Text] [Related]
15. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
[TBL] [Abstract][Full Text] [Related]
16. Collateral damage of flomoxef therapy: in vivo development of porin deficiency and acquisition of blaDHA-1 leading to ertapenem resistance in a clinical isolate of Klebsiella pneumoniae producing CTX-M-3 and SHV-5 beta-lactamases.
Lee CH; Chu C; Liu JW; Chen YS; Chiu CJ; Su LH
J Antimicrob Chemother; 2007 Aug; 60(2):410-3. PubMed ID: 17576696
[TBL] [Abstract][Full Text] [Related]
17. Resistance to extended-spectrum beta-lactams by the emergence of SHV-12 and the loss of OmpK35 in Klebsiella pneumoniae and Escherichia coli in Malaysia.
Palasubramaniam S; Muniandy S; Navaratnam P
J Microbiol Immunol Infect; 2009 Apr; 42(2):129-33. PubMed ID: 19597644
[TBL] [Abstract][Full Text] [Related]
18. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss.
Lee K; Yong D; Choi YS; Yum JH; Kim JM; Woodford N; Livermore DM; Chong Y
Int J Antimicrob Agents; 2007 Feb; 29(2):201-6. PubMed ID: 17204406
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Qnr determinants among bloodstream isolates of Escherichia coli and Klebsiella pneumoniae in a Taiwanese hospital, 1999-2005.
Wu JJ; Ko WC; Wu HM; Yan JJ
J Antimicrob Chemother; 2008 Jun; 61(6):1234-9. PubMed ID: 18356152
[TBL] [Abstract][Full Text] [Related]
20. Multiple antibiotic-resistance mechanisms including a novel combination of extended-spectrum beta-lactamases in a Klebsiella pneumoniae clinical strain isolated in Argentina.
Melano R; Corso A; Petroni A; Centrón D; Orman B; Pereyra A; Moreno N; Galas M
J Antimicrob Chemother; 2003 Jul; 52(1):36-42. PubMed ID: 12775675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
